Kaku, K.; Sato, T.; Takeuchi, J.; Yokoyama, K.; Yagi, S.; Takagi, Y.; Ikenouchi, M.; Kawai, M.; Kamikozuru, K.; Yokoyama, Y.;
et al. Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study. J. Clin. Med. 2025, 14, 5588.
https://doi.org/10.3390/jcm14155588
AMA Style
Kaku K, Sato T, Takeuchi J, Yokoyama K, Yagi S, Takagi Y, Ikenouchi M, Kawai M, Kamikozuru K, Yokoyama Y,
et al. Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study. Journal of Clinical Medicine. 2025; 14(15):5588.
https://doi.org/10.3390/jcm14155588
Chicago/Turabian Style
Kaku, Koji, Toshiyuki Sato, Jiro Takeuchi, Keiko Yokoyama, Soichi Yagi, Yasuhiro Takagi, Maiko Ikenouchi, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama,
and et al. 2025. "Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study" Journal of Clinical Medicine 14, no. 15: 5588.
https://doi.org/10.3390/jcm14155588
APA Style
Kaku, K., Sato, T., Takeuchi, J., Yokoyama, K., Yagi, S., Takagi, Y., Ikenouchi, M., Kawai, M., Kamikozuru, K., Yokoyama, Y., Takagawa, T., Tomita, T., Fukui, H., & Shinzaki, S.
(2025). Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study. Journal of Clinical Medicine, 14(15), 5588.
https://doi.org/10.3390/jcm14155588